PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Elutia Inc.

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Elutia Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.

What stands out

  • Cash Locked Ratio: For every $100 of sales, $101 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $82 tied up three years earlier. More money tied up than almost all Healthcare companies in United States.
  • Debt Due Cover Ratio: Operating cash was negative last year, while some debt falls due within a year. Lower than 87% of Healthcare companies in United States.
  • Cash Cushion Ratio: Cash, after subtracting all debt, equals 85% of its market value (net cash). Higher than 86% of Healthcare companies in United States.

Cash quality

Profit Cash Ratio

—

Loss-making or profit too small

Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.

Self-Funding Ratio

-31.0×

Over the last 3 years operating cash was negative while the company kept spending on investment (capex).

Lower than 66% of Healthcare companies in United States.

Cash Locked Ratio

$101

For every $100 of sales, $101 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $82 tied up three years earlier.

More money tied up than almost all Healthcare companies in United States.

Growth quality

Steadiness Ratio

1/3 · 1/3

Sales grew in 1 of the last 3 years; profit grew in 1 of 3.

Less steady than 70% of Healthcare companies in United States.

Growth Efficiency Ratio

—

Sales fell 48%

Sales fell 48% in 3 years, so extra profit per extra sales cannot be measured.

Asset Productivity Ratio

-48% / -9%

In 3 years sales changed by -48% while total assets changed by -9%. Assets grew faster than sales.

Balance-sheet strength

Debt Due Cover Ratio

-126.2×

Operating cash was negative last year, while some debt falls due within a year.

Lower than 87% of Healthcare companies in United States.

Cash Cushion Ratio

+85%

Cash, after subtracting all debt, equals 85% of its market value (net cash).

Higher than 86% of Healthcare companies in United States.

Tangible Assets Ratio

98%

Of every $100 the company owns, $98 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

More tangible than 82% of Healthcare companies in United States.

Tangible Net Worth Ratio

94%

Of every $100 of net worth, $94 is tangible; the rest is goodwill and other intangibles, often from buying other companies.

More tangible than 79% of Healthcare companies in United States.

Shareholders

Shareholder Slice Ratio

+262%

Share count rose 262% in 3 years, so each share's slice of the company became smaller.

Bigger rise in share count than 81% of Healthcare companies in United States.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (12)

Elutia Inc. made a loss over the last year. Elutia Inc. owes $0.64 for every $1 it owns. Elutia Inc. returned to profit in the year to Dec 2025, after a loss the year before.

Compared with Healthcare companies in United States · latest annual results Dec 2025.

P/E ratio

Loss

Elutia Inc. made a loss over the last year, so its P/E ratio is not meaningful.

P/B ratio

2.42

The share price is 2.42 times Elutia Inc.'s book value per share, lower than 52% of Healthcare companies in United States.

Market cap

$38 M

The total market value of all of Elutia Inc.'s shares at today's price (share price × number of shares), smaller than 77% of Healthcare companies in United States. PosiCap size class: Micro Cap.

Net worth (book value)

$16 M

What Elutia Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

$0.36

Net worth divided by the number of shares. The share price of $0.86 is 2.4 times this, which is the P/B above.

Owes vs Owns

0.64×

Elutia Inc. owes $0.64 for every $1 it owns (moderate), higher than 67% of Healthcare companies in United States.

Dividend yield

None

Elutia Inc. does not currently pay a dividend.

Revenue growth

-15%

Revenue fell 15% in the year to Dec 2025, and shrank 20% a year on average over 3 years.

Profit growth

Back to profit

Elutia Inc. returned to profit in the year to Dec 2025, after a loss the year before.

Profit margin

434.2%

Elutia Inc. keeps $434 of every $100 of revenue as net profit.

Cash quality

-0.8×

Cash from Elutia Inc.'s business was -0.8× its reported profit in the year to Dec 2025 — the business used cash even though it reported a profit.

Cash vs debt

Net cash

Elutia Inc. held $32 M more cash than debt (net cash) at Dec 2025.

Questions

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Elutia Inc.: $38 M ÷ $16 M (30 Jun 2026) = 2.4.

How much does Elutia Inc. owe compared with what it owns?

Elutia Inc. owes $0.64 for every $1 it owns (moderate), higher than 67% of Healthcare companies in United States.

Does Elutia Inc. pay a dividend?

No. Elutia Inc. does not currently pay a dividend.

Is Elutia Inc.'s revenue growing?

Revenue fell 15% in the year to Dec 2025, and shrank 20% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.